UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 184

Sortiert nach

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

The Journal of clinical investigation, 2020-10, Vol.130 (10), p.5380-5396

2020

Volltextzugriff (PDF)

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

Annals of surgery, 2021-02, Vol.273 (2), p.341

2021

Volltextzugriff (PDF)

YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity

Molecular cancer research, 2018-10, Vol.16 (10), p.1556-1567

2018

Volltextzugriff (PDF)

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma

Hepatology (Baltimore, Md.), 2012-02, Vol.55 (2), p.465-475

2012

Volltextzugriff (PDF)

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early-Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study

Journal of the American College of Surgeons, 2016-07, Vol.223 (1), p.52-65

2016

Volltextzugriff (PDF)

Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma

Cancer research (Chicago, Ill.), 2013-01, Vol.73 (2), p.897-907

2013

Volltextzugriff (PDF)

Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches

Journal of the American College of Surgeons, 2015-09, Vol.221 (3), p.689-698

2015

Volltextzugriff (PDF)

Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation

Journal of cellular biochemistry, 2018-01, Vol.119 (1), p.824-836

2018

Volltextzugriff (PDF)

The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma

Molecular cancer research, 2020-10, Vol.18 (10), p.1574-1588

2020

Volltextzugriff (PDF)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Scientific reports, 2023-09, Vol.13 (1), p.15980-15980, Article 15980

2023

Volltextzugriff (PDF)

Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience

The oncologist (Dayton, Ohio), 2018-01, Vol.23 (1), p.128-134

2018

Volltextzugriff (PDF)

FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma

Journal of the National Comprehensive Cancer Network, 2022-09, Vol.20 (9), p.1023

2022

Volltextzugriff (PDF)

Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy

Surgery, 2020-05, Vol.167 (5), p.803-811

2020

Volltextzugriff (PDF)

YAP-associated chromosomal instability and cholangiocarcinoma in mice

Oncotarget, 2018-01, Vol.9 (5), p.5892-5905

2018

Volltextzugriff (PDF)

Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis

Journal of surgical oncology, 2016-09, Vol.114 (4), p.475-482

2016

Volltextzugriff (PDF)

Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

Hepatology (Baltimore, Md.), 2009-12, Vol.50 (6), p.1861-1870

2009

Volltextzugriff (PDF)

Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the Liver

American journal of clinical pathology, 2020-12, Vol.154 (6), p.837-847

2020

Volltextzugriff (PDF)

Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)

International journal of surgery (London, England), 2018-04, Vol.52, p.171-179

2018

Volltextzugriff (PDF)

HCC in Cirrhotics With Retained Liver Function and Absent Portal Hypertension: Still a Surgical Disease

International journal of radiation oncology, biology, physics, 2018-12, Vol.102 (5), p.1405-1405

Smoot, Rory L.

2018

Volltextzugriff (PDF)

The utility of futility

Hepatology (Baltimore, Md.), 2024-02, Vol.79 (2), p.264-266

2024

Volltextzugriff (PDF)

Durability of Portal Venous Reconstruction Following Resection During Pancreaticoduodenectomy

Journal of gastrointestinal surgery, 2006-12, Vol.10 (10), p.1371-1375

2006

Volltextzugriff (PDF)

Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States

Cancers, 2023-01, Vol.15 (3), p.840

2023

Volltextzugriff (PDF)

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

Frontiers in oncology, 2021-05, Vol.11, p.651119-651119

2021

Volltextzugriff (PDF)

Transcriptomic landscapes of effective and failed liver regeneration in humans

JHEP reports, 2023-04, Vol.5 (4), p.100683, Article 100683

2023

Volltextzugriff (PDF)

Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients

BMC surgery, 2020-07, Vol.20 (1), p.1-169, Article 169

2020

Volltextzugriff (PDF)

1 – 25 von 184

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(154)

Publikationsform

Sprache

Englisch
(184)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity

miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early-Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study

Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma

Clinical Risk Score to Predict Pancreatic Fistula after Pancreatoduodenectomy: Independent External Validation for Open and Laparoscopic Approaches

Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation

The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience

FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma

Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy

YAP-associated chromosomal instability and cholangiocarcinoma in mice

Implications of CA19-9 elevation for survival, staging, and treatment sequencing in intrahepatic cholangiocarcinoma: A national cohort analysis

Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the Liver

Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)

HCC in Cirrhotics With Retained Liver Function and Absent Portal Hypertension: Still a Surgical Disease

The utility of futility

Durability of Portal Venous Reconstruction Following Resection During Pancreaticoduodenectomy

Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

Transcriptomic landscapes of effective and failed liver regeneration in humans

Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients

Suchergebnisse filtern